Status:
UNKNOWN
Extracorporeal Shock Wave Therapy for Pain-Relief After Arthroscopy for Osteochondral Lesions of the Talus
Lead Sponsor:
Southwest Hospital, China
Conditions:
Osteochondral Lesion of Talus
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Arthroscopic surgery is effective in treating osteochondral lesions of the talus. However, there are still some patients with postoperative ankle pain. This study aims to investigate the clinical effi...
Detailed Description
Arthroscopic surgery is effective in treating osteochondral lesions of the talus. However, there are still some patients with postoperative ankle pain. This study was conducted to investigate the clin...
Eligibility Criteria
Inclusion
- For arthroscopy:
- Ankle pain, aggravated after exercise or weight-bearing activity, accompanied by lameness, joint stiffness and dysfunction for at least 3 months
- No talar collapse
- Talar cartilage injury cases before stage Ⅳ of Hepple classification
- For shock wave therapy:
- Patients with micro-fractures treated with arthroscopic treatment of talar cartilage injury and were treated with routine rehabilitation training after arthroscopy
- Patients who till complained obvious ankle pain 3 months after surgery
Exclusion
- Severe cardiovascular and cerebrovascular diseases
- Hemorrhagic diseases, coagulation disorders
- Bone immaturity
- Thrombosis
- Use of anti-immune agents
- Various types of tumor patients
- Pregnant women
- History of mental illness
- Patients who could not be followed
- Patients with other lower extremity injuries after surgery and were unwilling to participate in the study
Key Trial Info
Start Date :
March 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2019
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT03750253
Start Date
March 1 2013
End Date
July 1 2019
Last Update
March 22 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Southwest Hospital
Chongqing, China